newsfilter
← Latest News
GlobeNewswire·

Homology Medicines Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Highlights

- Formed New AAV Manufacturing and Innovation Business with Oxford Biomedica to Leverage Homology's Process Development and Manufacturing Capabilities - - Received $130 Million Non-Dilutive Capital that Significantly Extends Cash Runway - - Launche